Obermatt

Zimmer

NYQ:ZBH · US98956P1021
Health Care Equipment & SuppliesX-Large

360

40
EV / EBIT97
Price / Owner Earnings83
Owner Earnings Yield93
Dividend Yield100
Price/Sales62
EV / Gross Profit75
Price/Book61
Return on Capital21
Cash Return on Capital37
Return on Equity21
EBIT Margin60
Gross Profitability22
Cash Conversion79
Accruals21
Owner Earnings Margin77
Sales growth25
Profit Growth98
Long-Term EPS Growth29
Owner Earnings Growth40
Reinvestment21
Price momentum58
Debt load47
Refinancing80
Debt Payback17
Liquidity82
Analyst ratings9
Opinion Changes43
Price Target Upside28
Market mood41
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Zimmer clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded2001
Employees12,989
ISINUS98956P1021
Last UpdateApr 2, 2026
Themes
Biomedical EngineeringNeurologyArtificial IntelligenceOrthopaedicsSurgeryDentalHealth CareManufacturingMedical Device

Description

Zimmer Biomet Holdings, Inc. (Zimmer Biomet) designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; bone cement; surgical pr…

Analysis

Bargain bin

Zimmer Biomet Holdings, Inc. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is attractive. The owner-earnings multiple stands at 12.6×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 0% a year, against analyst forecasts of 6%. The price, in other words, assumes less than the experts do.

Growth is tepid; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
96
2023202420252026

All-time high

96

Jun 2026

All-time low

18

Jan 2023

Average rank

70

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
62
50
53
64
Price/Earnings
31
87
78
90
Price/Book
61
67
82
93
Dividend Yield
100
92
90
89
Value (overall)
98
94
100
100

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Zimmer with its peers
Vivani Medical
NAQ:VANI
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Spectral AI
NAQ:MDAI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Senseonics
NSQ:SENS
7
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SANUWAVE Health
NMQ:SNWV
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →